News

Session Topic is the Innovation and Current Directions in Military Suicide Prevention, Research, and ProgramsPresentation ...
Study highlights novel epigenomic modulation in the central nervous system as a key mechanism for SRP-001's analgesic effects ...
Second antibody-drug conjugate (ADC) to progress into clinical development utilizing our proprietary payload and optimized antibodyPreclinical results demonstrate strong anti-tumor activity and favora ...
Poster presentation of updated data on BT-001 from the Phase 1 part of the ongoing Phase 1/2a study in solid tumors - LUND, SE / ACCESS Newswire / July 28, 2025 / BioInvent International AB ("BioInven ...
Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...
The rapid emergence and re-emergence of viral pathogens—exemplified by outbreaks of influenza, Ebola, Zika, and, most recently, SARS-CoV-2—underscore the ...
The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.
Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...
Transparent expectation-setting and addressing potential disappointments can foster safety, reduce anxiety, and promote ...
The new drug forces fat cells to produce more energy and doesn't impact appetite or muscle mass, unlike some existing ...
Durham-based TruTechnologies has secured a strategic growth investment from LLR Partners to accelerate the expansion of its real-time clinical trial oversight solutions and fuel the next phase of ...
A team of researchers has recently developed a nondestructive imaging and machine learning system that accurately predicts ...